[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100556059":3},{"organization":4,"armGroups":7,"interventions":30,"overallOfficials":89,"centralContacts":93,"locations":102,"responsibleParty":307,"collaborators":309,"id":335,"slug":48,"hasResults":336,"nctId":337,"briefTitle":338,"officialTitle":339,"acronym":48,"eligibilityCriteria":340,"healthyVolunteers":336,"sex":341,"minAge":342,"maxAge":343,"enrollmentInfo":344,"targetDuration":48,"studyType":347,"phases":348,"briefSummary":350,"conditions":351,"keywords":354,"overallStatus":105,"whyStopped":48,"lastUpdateSubmitDate":358,"lastUpdatePostDateStruct":359,"startDateStruct":362,"completionDateStruct":364,"leadSponsor":366,"locationsCount":367},{"fullName":5,"class":6},"The Affiliated People's Hospital of Ningbo University","OTHER_GOV",[8,17],{"label":9,"type":10,"description":11,"interventionNames":12},"EAP regimen group","EXPERIMENTAL","66 subjects will be enrolled into the EAP regimen group. EAP regimen is the etoposide, cytarabine, and PEG-rhG-CSF combination therapy.",[13,14,15,16],"Drug: Etoposide","Drug: Cytarabine","Drug: PEG-rhG-CSF","Drug: G-CSF",{"label":18,"type":19,"description":20,"interventionNames":21},"Disease-specific chemotherapy mobilization regimens group","ACTIVE_COMPARATOR","33 subjects will be enrolled into the disease-specific chemotherapy mobilization regimens group. The disease-specific chemotherapy mobilization regimens include but not limited to: CHOP, Hyper-CVAD, ID-MTX+Ara-C.",[22,23,24,25,26,27,28,29,16],"Combination Product: CHOP","Combination Product: Hyper-CVAD","Combination Product: ID-MTX + Ara-C","Combination Product: DA-EPOCH","Combination Product: GDP","Combination Product: GDPE","Combination Product: ICE","Combination Product: DICE",[31,38,44,49,53,58,62,66,70,74,78,82,86],{"type":32,"name":33,"description":34,"armGroupLabels":35,"otherNames":36},"DRUG","Etoposide","Day 1\\~Day 2: 75mg\u002Fm\\^2",[9],[37],"VP-16",{"type":32,"name":39,"description":40,"armGroupLabels":41,"otherNames":42},"Cytarabine","Day 1\\~Day 2: 200g\u002Fm\\^2, q12h",[9],[43],"Ara-C",{"type":32,"name":45,"description":46,"armGroupLabels":47,"otherNames":48},"PEG-rhG-CSF","Day 6: 6mg",[9],null,{"type":32,"name":50,"description":51,"armGroupLabels":52,"otherNames":48},"G-CSF","Starting from the 9th day, if the white blood cell count is less than 20,000\u002FμL, administer G-CSF at a dose of 5μg\u002Fkg by subcutaneous injection until the collection is completed.",[9],{"type":54,"name":55,"description":56,"armGroupLabels":57,"otherNames":48},"COMBINATION_PRODUCT","CHOP","\\[Cyclophosphamide (Cy) + Doxorubicin (ADM) + Vincristine (VDS) + Prednisone (Pred) \\]± Rituximab (R)",[18],{"type":54,"name":59,"description":60,"armGroupLabels":61,"otherNames":48},"Hyper-CVAD","\\[Cyclophosphamide + Doxorubicin + Vincristine + Dexamethasone (DXM)\\] ± Rituximab",[18],{"type":54,"name":63,"description":64,"armGroupLabels":65,"otherNames":48},"ID-MTX + Ara-C","\\[High-Dose Methotrexate (MTX) + Cytarabine\\] ± Rituximab",[18],{"type":54,"name":67,"description":68,"armGroupLabels":69,"otherNames":48},"DA-EPOCH","\\[Etoposide + Doxorubicin + Vincristine + Cyclophosphamide + Prednisone\\] ± Rituximab",[18],{"type":54,"name":71,"description":72,"armGroupLabels":73,"otherNames":48},"GDP","\\[Gemcitabine (G) + Cisplatin (P) + Dexamethasone (DXM)\\] ± Rituximab",[18],{"type":54,"name":75,"description":76,"armGroupLabels":77,"otherNames":48},"GDPE","\\[Gemcitabine + Cisplatin + Dexamethasone + Etoposide\\] ± Rituximab",[18],{"type":54,"name":79,"description":80,"armGroupLabels":81,"otherNames":48},"ICE","\\[Etoposide + Ifosfamide (IFO) + Carboplatin\\] ± Rituximab",[18],{"type":54,"name":83,"description":84,"armGroupLabels":85,"otherNames":48},"DICE","\\[Dexamethasone + Ifosfamide + Ifosfamide + Etoposide\\] ± Rituximab",[18],{"type":32,"name":50,"description":87,"armGroupLabels":88,"otherNames":48},"From Day 6, administer G-CSF at a dose of 5μg\u002Fkg by subcutaneous injection until the collection is completed.",[18],[90],{"name":91,"affiliation":5,"role":92},"Peipei Ye","PRINCIPAL_INVESTIGATOR",[94,98],{"name":91,"role":95,"phone":96,"phoneExt":48,"email":97},"CONTACT","86-13685832706","39612903@qq.com",{"name":99,"role":95,"phone":100,"phoneExt":48,"email":101},"Ying Lu","86-13486090834","814871416@qq.com",[103,120,134,144,154,167,180,193,203,216,229,238,251,261,274,284,297],{"facility":104,"status":105,"city":106,"state":107,"zip":48,"country":108,"cosmosGeoPoint":109,"geoPoint":114,"contacts":115},"Dongyang People's Hospital","RECRUITING","Dongyang","Zhejiang","China",{"type":110,"coordinates":111},"Point",[112,113],120.22528,29.26778,{"lat":113,"lon":112},[116],{"name":117,"role":95,"phone":118,"phoneExt":48,"email":119},"Gongqiang Wu","13757950788","Wugongqiang59@126.com",{"facility":121,"status":105,"city":122,"state":107,"zip":123,"country":108,"cosmosGeoPoint":124,"geoPoint":128,"contacts":129},"The Affiliated Hangzhou First People's Hospital","Hangzhou","310006",{"type":110,"coordinates":125},[126,127],120.16142,30.29365,{"lat":127,"lon":126},[130],{"name":131,"role":95,"phone":132,"phoneExt":48,"email":133},"Xiangmin Tong","+86-13750816623","tongxiangmin@163.com",{"facility":135,"status":105,"city":122,"state":107,"zip":48,"country":108,"cosmosGeoPoint":136,"geoPoint":138,"contacts":139},"The First Affiliated Hospital, College of Medicine, Zhejiang University",{"type":110,"coordinates":137},[126,127],{"lat":127,"lon":126},[140],{"name":141,"role":95,"phone":142,"phoneExt":48,"email":143},"Jie Jin","13507016779","jiej0503@163.com",{"facility":145,"status":105,"city":122,"state":107,"zip":48,"country":108,"cosmosGeoPoint":146,"geoPoint":148,"contacts":149},"Tongde Hospital of Zhejiang Province",{"type":110,"coordinates":147},[126,127],{"lat":127,"lon":126},[150],{"name":151,"role":95,"phone":152,"phoneExt":48,"email":153},"Huifang Jiang","13957182087","Jianghuifang501@163.com",{"facility":155,"status":105,"city":156,"state":107,"zip":48,"country":108,"cosmosGeoPoint":157,"geoPoint":161,"contacts":162},"Huzhou central hospital","Huzhou",{"type":110,"coordinates":158},[159,160],120.0933,30.8703,{"lat":160,"lon":159},[163],{"name":164,"role":95,"phone":165,"phoneExt":48,"email":166},"Lihong Shou","13587206019","SLH077@126.COM",{"facility":168,"status":105,"city":169,"state":107,"zip":48,"country":108,"cosmosGeoPoint":170,"geoPoint":174,"contacts":175},"The First Hospital of Jiaxing","Jiaxing",{"type":110,"coordinates":171},[172,173],120.75,30.7522,{"lat":173,"lon":172},[176],{"name":177,"role":95,"phone":178,"phoneExt":48,"email":179},"Hui Zeng","13957330440","zhwuhan@163.com",{"facility":181,"status":105,"city":182,"state":107,"zip":48,"country":108,"cosmosGeoPoint":183,"geoPoint":187,"contacts":188},"Jinhua Municipal Central Hospital","Jinhua",{"type":110,"coordinates":184},[185,186],119.64421,29.10678,{"lat":186,"lon":185},[189],{"name":190,"role":95,"phone":191,"phoneExt":48,"email":192},"Jingcheng Zhang","13958480529","zjc1983@126.com",{"facility":194,"status":105,"city":182,"state":107,"zip":48,"country":108,"cosmosGeoPoint":195,"geoPoint":197,"contacts":198},"Jinhua People's Hospital",{"type":110,"coordinates":196},[185,186],{"lat":186,"lon":185},[199],{"name":200,"role":95,"phone":201,"phoneExt":48,"email":202},"Li Huang","13566782316","huanglixiaoyu@126.com",{"facility":204,"status":105,"city":205,"state":107,"zip":48,"country":108,"cosmosGeoPoint":206,"geoPoint":210,"contacts":211},"Lishui Central Hospital","Lishui",{"type":110,"coordinates":207},[208,209],119.91029,28.46042,{"lat":209,"lon":208},[212],{"name":213,"role":95,"phone":214,"phoneExt":48,"email":215},"Linjie Li","13567615761","Lilinjie0394@163.com",{"facility":217,"status":105,"city":218,"state":107,"zip":48,"country":108,"cosmosGeoPoint":219,"geoPoint":223,"contacts":224},"Ningbo Medical Center Lihuili Hospital","Ningbo",{"type":110,"coordinates":220},[221,222],121.54945,29.87819,{"lat":222,"lon":221},[225],{"name":226,"role":95,"phone":227,"phoneExt":48,"email":228},"Jing Le","13566511755","nblejing@aliyun.com",{"facility":5,"status":105,"city":218,"state":107,"zip":48,"country":108,"cosmosGeoPoint":230,"geoPoint":232,"contacts":233},{"type":110,"coordinates":231},[221,222],{"lat":222,"lon":221},[234,236],{"name":91,"role":95,"phone":235,"phoneExt":48,"email":97},"13685832706",{"name":99,"role":95,"phone":237,"phoneExt":48,"email":101},"13486090834",{"facility":239,"status":105,"city":240,"state":107,"zip":48,"country":108,"cosmosGeoPoint":241,"geoPoint":245,"contacts":246},"Shaoxing People's Hospital","Shaoxing",{"type":110,"coordinates":242},[243,244],120.57864,30.00237,{"lat":244,"lon":243},[247],{"name":248,"role":95,"phone":249,"phoneExt":48,"email":250},"Weiying Feng","13588570250","fengweiying1997@126.com",{"facility":252,"status":105,"city":240,"state":107,"zip":48,"country":108,"cosmosGeoPoint":253,"geoPoint":255,"contacts":256},"Shaoxing Second Hospital",{"type":110,"coordinates":254},[243,244],{"lat":244,"lon":243},[257],{"name":258,"role":95,"phone":259,"phoneExt":48,"email":260},"Weiguo Zhu","18767509030","yin990216@sina.com",{"facility":262,"status":105,"city":263,"state":107,"zip":48,"country":108,"cosmosGeoPoint":264,"geoPoint":268,"contacts":269},"Taizhou Central Hospital","Taizhou",{"type":110,"coordinates":265},[266,267],121.43312,28.66266,{"lat":267,"lon":266},[270],{"name":271,"role":95,"phone":272,"phoneExt":48,"email":273},"Sai Chen","13575809591","chens7111@tzzxyy.com",{"facility":275,"status":105,"city":263,"state":107,"zip":48,"country":108,"cosmosGeoPoint":276,"geoPoint":278,"contacts":279},"Taizhou Hospital of Zhejiang Province",{"type":110,"coordinates":277},[266,267],{"lat":267,"lon":266},[280],{"name":281,"role":95,"phone":282,"phoneExt":48,"email":283},"Qunyi Guo","13515861286","guoqunyi@163.com",{"facility":285,"status":105,"city":286,"state":107,"zip":48,"country":108,"cosmosGeoPoint":287,"geoPoint":291,"contacts":292},"The Second Affiliated Hospital of Wenzhou Medical University","Wenzhou",{"type":110,"coordinates":288},[289,290],120.66682,27.99942,{"lat":290,"lon":289},[293],{"name":294,"role":95,"phone":295,"phoneExt":48,"email":296},"Ying Lin","13705883857","wzly1974@hotmail.com",{"facility":298,"status":105,"city":286,"state":48,"zip":48,"country":108,"cosmosGeoPoint":299,"geoPoint":301,"contacts":302},"The First Affiliated Hospital of Wenzhou Medical University",{"type":110,"coordinates":300},[289,290],{"lat":290,"lon":289},[303],{"name":304,"role":95,"phone":305,"phoneExt":48,"email":306},"Shujuan Zhou","13738368586","Zhousj320@163.com",{"type":308,"investigatorFullName":48,"investigatorTitle":48,"investigatorAffiliation":48,"oldNameTitle":48,"oldOrganization":48},"SPONSOR",[310,313,315,317,318,320,321,322,324,326,327,329,331,333,334],{"name":311,"class":312},"First Affiliated Hospital of Zhejiang University","OTHER",{"name":314,"class":312},"First Affiliated Hospital of Wenzhou Medical University",{"name":316,"class":312},"Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University",{"name":194,"class":312},{"name":319,"class":312},"The Central Hospital of Lishui City",{"name":239,"class":312},{"name":252,"class":312},{"name":323,"class":312},"Zhejiang Provincial Tongde Hospital",{"name":325,"class":312},"Taizhou Hospital",{"name":104,"class":312},{"name":328,"class":312},"Affiliated Hospital of Jiaxing University",{"name":330,"class":312},"Huzhou Central Hospital",{"name":332,"class":312},"Second Affiliated Hospital of Wenzhou Medical University",{"name":217,"class":6},{"name":181,"class":312},"100556059",false,"NCT06520163","Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma","A Prospective, Multicenter, Randomized Controlled Trial Comparing the Efficacy and Safety of Etoposide, Cytarabine, and PEG-rhG-CSF Combination Therapy vs. Disease-Specific Chemotherapy for Hematopoietic Stem Cell Mobilization in Lymphoma","Inclusion Criteria:\n\n* Diagnosed with non-Hodgkin's lymphoma before enrollment.\n* Indication for autologous stem cell transplantation (ASCT).\n* Eastern Cooperative Oncology Group (ECOG) performance status of 0\\~1.\n* Achieved complete remission after multiple courses of chemotherapy.\n* Life expectancy ≥ 3 months.\n* Subjects must be able to understand the protocol and sign the informed consent.\n\nExclusion Criteria:\n\n* Cardiac function class II or higher or cardiac ejection fraction \\\u003C 40%.\n* Serum direct bilirubin (DBIL) more than twice of the upper limit of normal (ULN).\n* Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) more than three times the upper limit of normal (ULN).\n* Serum creatinine clearance rate ≤ 50%.\n* Patients with active infection.\n* History of prior hematopoietic stem cell mobilization.","ALL","18 Years","75 Years",{"count":345,"type":346},99,"ESTIMATED","INTERVENTIONAL",[349],"PHASE3","This study utilizes a prospective, multicenter, randomized two-arm design to evaluate the efficacy and safety of the etoposide, cytarabine, and pegylated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) combination therapy (EAP regimen) in mobilizing hematopoietic stem cells in patients with non-Hodgkin's lymphoma (NHL). A total of 99 NHL patients will be enrolled as research subjects and will be randomly allocated in a 2:1 ratio to compare the EAP regimen versus disease-specific chemotherapy mobilization regimen. The primary endpoint is the proportion of patients achieving the ideal collection value after a single collection (CD34+ cells ≥5×10\\^6\u002Fkg).",[352,353],"Non-Hodgkin's Lymphoma","Hematopoietic Stem Cell Mobilization",[352,355,356,357],"Disease-Specific Chemotherapy","Hematopoietic stem cell mobilization","Etoposide, Cytarabine Combined with PEG-rhG-CSF","2025-11-27",{"date":360,"type":361},"2025-12-04","ACTUAL",{"date":363,"type":361},"2024-08-01",{"date":365,"type":346},"2026-08",{"name":5,"class":6},17]